Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered ...

Breast cancer survivors must remain vigilant for recurrence signs, which can manifest locally, regionally, or distantly. New ...

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...

WeGotThis.org founder and author Elissa Kalver wants to reframe the conversation around metastatic breast cancer.

A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced ...

In 2024, the U.S. FDA granted HYRNUO Breakthrough Therapy designation for the treatment of adult patients with unresectable or metastatic NSCLC whose tumors have activating HER2 (ERBB2) mutations, and ...

A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology (JAIST), has discovered that the marine ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

Pancreatic cancer is projected to be the second leading cause of cancer deaths by 2030, but experts say Ireland is failing ...

Key PointsFirst demonstration that the marine bacterium Photobacterium angustum exhibits potent antitumor effects against colorectal cancerNatural ...

A woman says she was left "blindsided" when her grandad died from cancer just six days after his diagnosis. Emmie Kay, from ...

A 39-YEAR-old mum from Warrington has received the ‘earth-shattering’ news that she has incurable cancer. Nicola Finch, from ...